Overview

Motion Syros: A Randomized Study Investigating the Efficacy of Tradipitant in Treating Motion Sickness

Status:
Recruiting
Trial end date:
2020-09-01
Target enrollment:
0
Participant gender:
All
Summary
A multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy of tradipitant in the treatment of motion sickness.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Vanda Pharmaceuticals
Criteria
Inclusion Criteria:

- History of motion sickness

- Age 18-75

Exclusion Criteria:

- Nausea-inducing disorder other than motion sickness

- BMI>40

- History of intolerance and/or hypersensitivity to Neurokinin-1 Receptor antagonists